CANDACE COTHRAN: Open Payments
NPI 1679574370 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 87 payments from 17 companies in 2025. Trend: 2023 $933 · 2024 $1,318 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $321 |
| GlaxoSmithKline, LLC. | 20 | $264 |
| GENZYME CORPORATION | 19 | $261 |
| Novartis Pharmaceuticals Corporation | 7 | $190 |
| CSL Behring | 8 | $150 |
| PFIZER INC. | 3 | $71 |
| Lilly USA, LLC | 2 | $60 |
| Amgen Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $56 |
| Genentech USA, Inc. | 2 | $52 |
Products named: DUPIXENT, NUCALA, Hizentra, TEZSPIRE, FASENRA, Rhapsido, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
